Rapid design of combination antimicrobial therapy against Acinetobacter baumanniiCOMPUTERS & CHEMICAL ENGINEERINGIF3.92025-01-010PRE
Zileuton ameliorates aminoglycoside and polymyxin-associated acute kidney injury in an animal modelJOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62023-08-110PRE
Deciphering longitudinal optical-density measurements to guide clinical dosing regimen design: A model-based approachCOMPUTER METHODS AND PROGRAMS IN BIOMEDICINEIF4.82022-12-012OAAI
Clinical and genomic analysis of virulence-related genes in bloodstream infections caused by Acinetobacter baumanniiVIRULENCEIF5.42022-10-2811OAAI
Optimal ceftazidime/avibactam dosing exposure against KPC-producing Klebsiella pneumoniaeJOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62022-08-2915OA
Simultaneous in vitro simulation of multiple antimicrobial agents with different elimination half-lives in a pre-clinical infection modelCOMPUTERS & CHEMICAL ENGINEERINGIF3.92021-12-015OAAI
Experimental Validation of a Mathematical Framework to Simulate Antibiotics with Distinct Half-Lives Concurrently in an In Vitro ModelANTIBIOTICS-BASELIF4.62021-10-162OA
MIC profiling of ceftazidime/avibactam against two carbapenemase-producing Klebsiella pneumoniae isolatesJOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCEIF3.22020-12-012OAAI